Question Bank › Told to get bigger

Told to get bigger

Told to get bigger: management describes counterparties actively pressing the company to expand beyond what it currently

Calls Tested
484
Answered YES
10
Hit Rate
2.1%
rare by design

Biogen Inc. (BIIB) — this company's answers

NO on the Q2 2017 call 2017-07-25 B
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司的交易对手方(如客户、合作伙伴、支付方等)正在积极推动公司扩大规模或范围,并且公司正在响应这种外部压力。 在记录中,管理层多次提到外部压力。例如,在SPINRAZA部分,Michel提到“患者和倡导团体强烈要求”治疗,以及“患者和家属非常知情、积极并要求治疗”。此外,在MS部分,提到“价值导向合同”是应客户要求。但更关键的是,在SPINRAZA的讨论中,管理层提到“患者和倡导团体”推动治疗,以及“医生和患者”要求更多。然而,这些是否构成“交易对手方”推动公司扩大?患者是客户,他们要求治疗,但公司已经在提供治疗,只是面临物流挑战。管理层提到“我们正在与医生合作,了解最佳实践,包括替代给药方案”,这表示公司正在响应患者需求,但这是否是“扩大公司规模”? 更直接的是,在基因治疗部分,Mike提到“我们致力于为所有SMA患者提供解决方案”,但这是公司自己的战略。在MS部分,提到“价值导向合同”是公司主动推出的。 然而,有一个明确的例子:在SPINRAZA的讨论中,Michel说:“我们正在与医生、患者和支付方合作,以扩大尽可能多的SMA患者的获取。”这表示外部压力(患者、医生)要求更多,公司正在响应。但这是否是“扩大公司规模”?公司已经在提供SPINRAZA,只是需要解决给药问题。这更像是优化现有产品,而不是扩大公司业务范围。 另一个例子:在biosimilar部分,Michel提到“我们正在与支付方合作”,但这是公司自己的策略。 关键点:管理层是否描述了“交易对手方”明确要求公司提供更多?在SPINRAZA部分,患者和倡导团体要求治疗,但公司已经在提供,只是面临技术挑战。这更像是需求推动,但公司已经在供应,只是需要解决物流。这不算“扩大公司规模”。 在MS部分,价值导向合同是公司主动提出的,不是外部压力。 在基因治疗部分,公司自己决定投资。 因此,没有明确的外部压力要求公司扩大规模。管理层描述的是公司自己的战略和计划。 所以答案应为NO。

← Back to the full BIIB analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that the company's own COUNTERPARTIES ARE ACTIVELY PUSHING IT TO BECOME BIGGER OR BROADER THAN IT CURRENTLY IS — that is, customers, partners, distributors, payers, institutions, or other parties the company already does business with are asking, urging, or pressing the company to supply more than it can, to serve places or needs it does not yet serve, to take on scope it does not currently handle, or to build capability it does not yet have — and does management present this outside pressure as something it is CURRENTLY RESPONDING TO by expanding what the company does? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation with both halves present as a present-tense reality: (1) THE PUSH COMES FROM THE OTHER SIDE OF THE TABLE, AND IT IS FOR MORE THAN THE COMPANY PRESENTLY PROVIDES. Management describes identifiable counterparties — parties already doing business with the company or already engaged with it — asking it to go beyond its present form. Any genuine expression of this counts, and the form varies widely across industries. For example: customers asking for volumes, quantities, or capacity beyond what the company can currently produce or deliver; customers asking the company to serve additional locations, regions, sites, or countries where it has no presence; customers or partners asking it to take on additional scope, steps, products, services, or responsibility it does not currently handle for them; counterparties asking it to develop, adapt, or build something it does not yet offer; partners or institutions asking it to participate in programs, applications, or uses outside its current footprint; or counterparties urging it to add people, facilities, or capability so it can carry more of their business. What matters is that the initiative for enlargement is described as coming from OUTSIDE — the company is being pulled to grow by the people who buy from or work with it — rather than the company deciding on its own to expand and then going to look for demand. (2) THE COMPANY IS ACTUALLY MOVING TO MEET IT, NOW. Management describes real, already-underway response — capacity, facilities, people, products, geographies, capability, or scope being added, built, hired, developed, or extended in order to satisfy what these counterparties are asking for. The response must be in motion or committed, not merely under consideration, and management should treat responding to this pull as a significant part of what the company is presently working on. Management should convey, directly or plainly in substance, that what these counterparties are asking for is meaningful relative to the company's current size — enough that meeting it would leave the company noticeably larger or broader than the business the reported results describe — and that the resulting activity is mostly still ahead. Candor about the difficulty, cost, or strain of answering the pull strengthens rather than weakens a YES. The essence is ONE phenomenon: a company being enlarged by demand from its own counterparties rather than by its own ambition, and visibly reshaping itself in response. The industry, the counterparties, and the form of the requested enlargement may vary widely. Answer NO if the expansion described is the company's own idea, strategy, or initiative, however well justified, with no counterparties pressing for it. NO if the counterparties are simply buying more of what the company already provides in the ordinary way, however strongly — routine volume growth within the company's existing offering is not this phenomenon. NO if the requests are only inquiries, expressions of interest, exploratory conversations, or hypothetical possibilities, or if management describes them but is not doing anything about them yet. NO if the response is only planned, contemplated, budgeted, or contingent on financing, approvals, or decisions not yet obtained. NO if the requested enlargement is trivial relative to the company, or is the ordinary custom-request traffic every business in the industry handles. NO if management is chiefly declining, deferring, or narrowing rather than expanding to meet the pull. NO if the pull is described as coming from the market in general, industry conditions, or a large addressable opportunity rather than from identifiable counterparties actually asking. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
WEC WEC Energy Group, Inc. Q1 2024 2024-05-01 A
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
TSSI TSS, Inc. Q4 2022 2023-04-03 D
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
AKAM Akamai Technologies, Inc. Q4 2021 2022-02-15 B
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
ALB Albemarle Corporation Q3 2018 2018-11-08 B

How the model reasoned

LOPE · Q2 2021 → YESThe question is whether management describes counterparties actively pushing the company to become bigger or broader, and if they're currently responding by expanding. YES The transcript shows management describing counterparties actively pushing for expansion beyond current offerings. Specifically, one partner derives 14% of revenues from GCE/Orbis programs and "they want to do more," while institutions seek additional revenue streams. Management presents this as driving "rapid partnership growth," with partners having "the ability and desire to add additional programs.
WEC · Q1 2024 → YESThe question is whether management describes counterparties actively pushing the company to become bigger or broader, and if they're currently responding by expanding. YES The transcript shows management describing Microsoft (a major customer prospect) actively requesting expanded supply: they control 1,345 acres (up from 315), are in weekly technical discussions, and will need all their energy supplied by WEC.
GFS · Q3 2021 → YESThe question is: Does management describe that the company's own counterparties are actively pushing it to become bigger or broader than it currently is, and is management currently responding to this...

More from the question bank

Management is buying the same thing twiceThe new engine is already turningAnalysts converge on an emerging driverTempo shift: the rhythm of the business has Priced like the old business, running like aAfter the books closedAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.